Abstract
This article summarizes the principal publications and those evidence-based clinical trials on dyslipidemias, including their main findings and recommendations for practicing cardiologists and clinicians. Emphasis is given to the confirmed data regarding the pathophysiology as well as the diagnoses of dyslipidemias, and the established therapeutic approaches validated in multiple well supervised control trials. The basic recommendations provided by the American Heart Association and the American College of Cardiology are presented as well as a brief description of the objectives, findings and results of the most recognized control trials, particularly those whose results have been published from 2000 to 2008. The importance of aggressive therapy to reach target lipids goals other than LDL-cholesterol in mixed dyslipidemias with combination therapy is strongly pointed out and emphasized.
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).